Table 2

Descriptive table of the study population

VariablesCategoryControl (%)Case (%)Total (%)P value
Total286028605720
Age75–<80738 (27.38)738 (27.38)1476 (25.80)
80–<85831 (29.06)831 (29.06)1662 (29.06)
85–<90711 (24.86)711 (24.86)1422 (24.86)
≥90580 (20.28)580 (20.28)1160 (20.28)
GenderMale1657 (57.94)1657 (57.94)3314 (57.94)
Female1203 (42.06)1203 (42.06)2406 (42.06)
Use of PIMNo use of PIM2618 (91.54)2503 (87.52)5121 (89.53)
Use of PIM242 (8.46)357 (12.48)599 (10.47)0.001
Chronic conditions, n0324 (11.33)195 (6.82)519 (9.07)
1408 (14.27)278 (9.72)686 (11.99)
2–41285 (44.93)986 (34.48)2271 (39.70)
5–7619 (21.64)865 (30.24)1484 (25.94)
≥8224 (7.83)536 (18.74)760 (13.29)0.001
Medicines, n0422 (14.76)290 (10.14)712 (12.45)
1–41348 (47.13)917 (32.06)2265 (39.60)
5–9896 (31.33)1157 (40.45)2053 (35.89)
10–14172 (6.01)390 (13.64)562 (9.83)
≥1522 (0.77)106 (3.71)128 (2.24)0.001
  • PIM, potential inappropriate medicine.